Ontology highlight
ABSTRACT: Introduction
Patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) become progressively impaired, with chronic pain, immobility and bladder, bowel and sexual dysfunction. Tested antiretroviral therapies have not been effective and most patients are offered a short course of corticosteroids or interferon-α, physiotherapy and symptomatic management. Pathogenesis studies implicate activated T-lymphocytes and cytokines in tissue damage. We therefore tested the hypothesis that inhibition of T-cell activation with ciclosporin A would be safe and clinically beneficial in patients with early and/or clinically progressing HAM/TSP.Materials and methods
Open label, proof of concept, pilot study of 48 weeks therapy with the calcineurin antagonist, ciclospori
SUBMITTER: Martin F
PROVIDER: S-EPMC3373656 | biostudies-literature | 2012
REPOSITORIES: biostudies-literature